UBS Group AG - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$202,584
-37.8%
64,931
-8.4%
0.00%
Q2 2023$325,509
+26.3%
70,917
+36.2%
0.00%
Q1 2023$257,672
+8.0%
52,055
+19.1%
0.00%
Q4 2022$238,651
+236.1%
43,709
+299.6%
0.00%
Q3 2022$71,000
-22.0%
10,939
-43.3%
0.00%
Q2 2022$91,000
+355.0%
19,303
+583.8%
0.00%
Q1 2022$20,000
-95.5%
2,823
-93.5%
0.00%
Q4 2021$445,000
+293.8%
43,715
+373.4%
0.00%
Q3 2021$113,0009,2340.00%
Other shareholders
MAXCYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
NORTH RUN CAPITAL, LP 480,900$3,361,0004.94%
Casdin Capital, LLC 13,971,334$97,660,0004.38%
Vitruvian Partners LLP 4,385,670$30,656,0003.25%
RIVER GLOBAL INVESTORS LLP 2,100,000$14,849,0001.95%
APIS CAPITAL ADVISORS, LLC 180,000$1,258,0001.52%
Pier Capital, LLC 1,017,753$7,114,0000.91%
First Light Asset Management, LLC 1,321,406$9,237,0000.82%
Montanaro Asset Management Ltd 929,000$6,557,0000.81%
Nicholas Investment Partners, LP 776,963$5,431,0000.39%
Bleichroeder LP 250,000$1,764,0000.31%
View complete list of MAXCYTE INC shareholders